Anna is a Director and Investment Committee member at Unilever Ventures, the London based venture arm of the Unilever Group, which she joined in 2003 from a background in financial advisory and venture capital investment. She is currently representing Unilever Ventures i.a. on the Boards of P2i, Catexel and Percolate Industries Inc having previously been a director of i.a. V Water, CyDen, PharmaKodex and BAC prior to Unilever Ventures’ successful exit from these companies.
Anna is Swedish. She lived in France for 12 years and holds a degree from the French graduate school of management ESSEC.